Apple Tree Partners
Edit

Apple Tree Partners

https://www.appletreepartners.com
Last activity: 19.02.2024
Invests in categories: MedtechDrugHealthTechBioTechHardwareProductTechnologyDevelopmentITHuman
News
522
Portfolio
34
Mentions
29
Investment Stage: Series A

Portfolio 34

DateNameWebsiteTotal RaisedLocation
10.01.2024redqueentx...--
08.11.2023ascidian-t...ascidian-t...$40M-
05.11.2023Lexicon Ph...lexpharma....-United Sta...
01.08.2023Aulos Bios...aulosbio.c...$20MUnited Sta...
12.01.2023aethontx.c...-United Sta...
15.12.2022deepapplet...deepapplet...$52M-
01.11.2022Evercrisp ...evercrispb...-United Sta...
17.09.2022Galvanize ...galvanizet...-United Sta...
27.01.2022Avid Radio...lilly.com-United Sta...
24.12.2021Initial Th...initialtx....$75MUnited Sta...
Show more

News 522

DateTitleDescription
14.02.2024Replicate Bioscience Announces Positive Initial Clinical Res...Replicate's srRNA vaccine elicited a protective immune response that met the WHO threshold for prote...
29.01.2024Ascidian Therapeutics Announces First-Ever IND for an RNA Ex...ACDN-01 is the first RNA exon editor to enter clinical development and the only clinical-stage thera...
29.01.2024Ascidian Therapeutics Announces First-Ever IND for an RNA Ex...ACDN-01 is the first RNA exon editor to enter clinical development and the only clinical-stage thera...
25.01.2024First Patient Dosed in Phase 2 Portion of Aulos Bioscience’s...Preliminary Phase 2 data in melanoma, renal cell carcinoma anticipated to be presented by mid-2024 ...
25.01.2024First Patient Dosed in Phase 2 Portion of Aulos Bioscience’s...-
05.01.2024Novel Compound Protects Against Infection by Virus that Caus...Stapled lipopeptides successfully deter infection by the SARS-CoV-2 virus and reduce the severity of...
05.01.2024Novel Compound Protects Against Infection by Virus that Caus...Stapled lipopeptides successfully deter infection by the SARS-CoV-2 virus and reduce the severity of...
18.12.2023Aulos Bioscience Advances AU-007 to Phase 2 Portion of Phase...Phase 2 study follows on positive Phase 1 data showing early anti-tumor activity in heavily pre-trea...
18.12.2023Aulos Bioscience Advances AU-007 to Phase 2 Portion of Phase...Phase 2 study follows on positive Phase 1 data showing early anti-tumor activity in heavily pre-trea...
14.12.2023Apple Tree Partners Unveils Deep Apple Therapeutics to Drama...Conducting entirely virtual screens of multi-billion molecule virtual libraries, Deep Apple can quic...
Show more

Mentions in press and media 29

DateTitleDescriptionSource
08.11.2023Ascidian Therapeutics Raises $40 Million in Series A Extensi...Funds from ATP will support the progress of Ascidian’s lead program in ABCA4 retinopathies, includin...appletreep...
08.11.2023Ascidian Therapeutics Raises $40 Million in Series A Extensi...Funds from ATP will support the progress of Ascidian’s lead program in ABCA4 retinopathies, includin...appletreep...
01.08.2023Aulos Bioscience Raises $20 Million in Series A Extension Fi...-appletreep...
01.08.2023Aulos Bioscience Raises $20 Million in Series A Extension Fi...Funds from ATP will continue to sustain the progress of Aulos’ novel IL-2 therapeutic AU-007 through...appletreep...
09.06.2022Curia and Replicate Bioscience Enter Strategic Collaboration...ALBANY, N.Y.–(BUSINESS WIRE)–June 9, 2022– Curia, formerly AMRI, a leading contract research, develo...venturebea...
11.01.2022Nine Square Therapeutics Appoints Robert Paul as CEOSOUTH SAN FRANCISCO, Calif., Jan. 11, 2022 /PRNewswire/ -- Nine Square Therapeutics, a biotechnology...marketscre...
07.12.2021Apple Tree Partners breaks into UK with biotech Adendra Ther...Apple Tree Partners has picked its first U.K.-based venture to launch: Adendra Therapeutics, an immu...fiercebiot...
08.09.2021ATP Announces $40 Million in Series A Funding for srRNA Ther...NEW YORK and SAN DIEGO, Sept. 8, 2021 /PRNewswire/ -- ATP, a leader in life sciences venture capital...marketscre...
08.09.2021ATP Announces $40 Million in Series A Funding for srRNA Ther...NEW YORK and SAN DIEGO, Calif., September 8, 2021/PR NEWSWIRE/ – ATP, a leader in life sciences vent...appletreep...
08.09.2021ATP Announces $40 Million in Series A Funding for srRNA Ther...NEW YORK and SAN DIEGO, Calif., September 8, 2021/PR NEWSWIRE/ – ATP, a leader in life sciences vent...appletreep...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In